1
/
of
1
Alpha BioMed
Cagrilintide/GLP-1 (2.5/2.5mg) - 2ml Vial
Cagrilintide/GLP-1 (2.5/2.5mg) - 2ml Vial
A provider account is required to view prices and to place orders. Click the button below to submit your application!
Have an account? Login here.
- Cagrilintide/GLP-1 (2.5/2.5mg) - 2ml Vial is a combination peptide formulation designed for investigative use in metabolic and appetite regulation research models. This dual-agent compound includes both a long-acting amylin analog (Cagrilintide) and a GLP-1 receptor agonist, facilitating synergistic modulation of satiety and glycemic pathways in preclinical settings.
- This formulation has been studied for its effects on energy homeostasis, gastric emptying, and appetite signaling, offering valuable insights into complex neuroendocrine mechanisms governing caloric intake and metabolic balance.
- Research indicates that the Cagrilintide/GLP-1 combination may enhance experimental outcomes in obesity and diabetes models by promoting sustained reductions in food intake and improvements in glucose tolerance.
- Investigators have explored this peptide pairing for its potential to influence body weight regulation, insulin sensitivity, and lipid profiles in animal and cellular models, making it a promising candidate for advanced metabolic research protocols.
- Cagrilintide/GLP-1 (2.5/2.5mg) - 2ml Vial is intended for laboratory research use only. This compound is ideal for institutions conducting studies on appetite regulation, metabolic disorders, and endocrine signaling.
